NUPLAZID (pimavanserin) 34 mg: The First and Only FDA-Approved Treatment for Parkinson's Disease Psychosis-Brief-1242
Jeff Boatman, NP
Please join us, Monday January 21st at, The Boundary, for our first Dinner Meeting of 2019!
Register today for your opportunity to network with other STLNAP Members. Dinner included during our presentation.